Bastiaan M Privé
7PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 12, 2025
A cost-effectiveness study of PSMA-PET/CT for the detection of clinically significant prostate cancer.Bastiaan M Privé, Tim M Govers, Bas Israël
|May 21, 2024
Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer.Bastiaan M Privé, Bas Israël, Marcel J R Janssen
|Dec 21, 2021
89Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in man.Bastiaan M Privé, Yvonne H W Derks, Florian Rosar
|Nov 05, 2021
Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.Bastiaan M Privé, Marcel J R Janssen, Inge M van Oort
|Jul 13, 2021
Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer.Bastiaan M Privé, Peter H J Slootbeek, Babette I Laarhuis
|Apr 22, 2021
Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study.Bastiaan M Privé, Steffie M B Peters, Constantijn H J Muselaers
Pageof 2
Frequent Collaborators
4 joint publications
Inge M van Oort
3 joint publications
Niven Mehra
3 joint publications
Jelle O Barentsz
3 joint publications
James Nagarajah
2 joint publications
Bas Israël
2 joint publications
Steffie M B Peters
1 joint publications
Diederik M Somford
1 joint publications
Jean-Paul A van Basten
1 joint publications
Sandra Heskamp
1 joint publications
Samer Ezziddin
